开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2024-04-15 ms8000000162197703 来自重庆

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：MRI;妇科影像
经验分享：3.17 submission
3.19 with editor
3.21 under review
4.1 Major revision
4.10 Revision Submitted
4.12 with editor
4.12 Minor revision
4.14 Revision Submitted
4.14 Accept
从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！

96 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2024-03-29 14697858m50(暂无昵称) 来自江苏省

大家with editor一般多久

77 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2024-06-28 菲菲菲-菲亦般来自湖北省

偏重的研究方向：影响医学与核医学
经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2024-07-15 菲菲菲-菲亦般来自湖北省

看见有人说选择OA会发在增刊上是什么意思呀

64 0

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2022-10-26 12114defm22(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0
经验分享：别选OA，发在了增刊上。

206 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2024-04-09 ms7000001717279760 来自安徽省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：影像组学;宫颈癌;IVIM-DWI
经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。

81 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2023-09-27 ms1000000817793480 来自上海

academic radiology拒稿以后，大修了还能重投吗

169 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2023-06-21 ms9000001805132895 来自江苏省

请教一下，没送审，直接decision in process 是不是已经凉凉了

194 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2020-02-14 Hanwin

审稿速度:1.0 | 投稿命中率:50.0
经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了

337 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198552, encodeId=e7802198552d0, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：MRI;妇科影像 经验分享：3.17 submission 3.19 with editor 3.21 under review 4.1 Major revision 4.10 Revision Submitted 4.12 with editor 4.12 Minor revision 4.14 Revision Submitted 4.14 Accept 从没想过人生第一次投稿就能一个月内就接收了，这个期刊的效率真的好高。而且审稿人的意见很中肯，按照意见一一补充实验，一一解答，就接收啦！！对这个期刊的好感up！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202404/b4a17add75554a68a8cb331f6b119b12-CIpB6jgaQvD1.jpg, createdBy=864c9192097, createdName=ms8000000162197703, createdTime=Mon Apr 15 09:23:43 CST 2024, time=2024-04-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2196158, encodeId=ce822196158d5, content=大家with editor一般多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri Mar 29 23:24:53 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212096, encodeId=7871221209645, content=偏重的研究方向：影响医学与核医学 经验分享：外审24天，required reviews completed 持续了五六天都没变，一般这个状态持续多久啊，诸位大佬指教, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Fri Jun 28 14:05:28 CST 2024, time=2024-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2214996, encodeId=f922221499617, content=看见有人说选择OA会发在增刊上是什么意思呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48758339924, createdName=菲菲菲-菲亦般, createdTime=Mon Jul 15 10:43:28 CST 2024, time=2024-07-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2096265, encodeId=00142096265fd, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：别选OA，发在了增刊上。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9ca2226709, createdName=12114defm22(暂无昵称), createdTime=Wed Oct 26 14:25:19 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197601, encodeId=5846219e60126, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：影像组学;宫颈癌;IVIM-DWI 经验分享：嘻嘻嘻，投4次，中3次我贼喜欢这个期刊。唯一的缺点就是单通讯。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Tue Apr 09 15:26:18 CST 2024, time=2024-04-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2160031, encodeId=d1442160031ce, content=academic radiology拒稿以后，大修了还能重投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44d08440014, createdName=ms1000000817793480, createdTime=Wed Sep 27 12:19:56 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144159, encodeId=26a221441592c, content=请教一下，没送审，直接decision in process 是不是已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7c8295689, createdName=ms9000001805132895, createdTime=Wed Jun 21 21:06:36 CST 2023, time=2023-06-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584714, encodeId=7472584e14f5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2-10 submit 2-13 accept 我个人见过最快的竟然自己体验了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1612438696, createdName=Hanwin, createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159447, encodeId=ffe9215944e94, content=这个杂志接受共通讯吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43008322822, createdName=ms7000001930113483, createdTime=Sun Sep 24 15:55:07 CST 2023, time=2023-09-24, status=1, ipAttribution=上海)]

2023-09-24 ms7000001930113483 来自上海

这个杂志接受共通讯吗

151 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务